{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:00:14Z","timestamp":1772107214851,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/nm1547","type":"journal-article","created":{"date-parts":[[2007,3,4]],"date-time":"2007-03-04T18:04:07Z","timestamp":1173031447000},"page":"348-353","source":"Crossref","is-referenced-by-count":142,"title":["ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor"],"prefix":"10.1038","volume":"13","author":[{"given":"Zhiming","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyuan","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Chia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane E","family":"Merry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Shi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chawnshang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,4]]},"reference":[{"key":"BFnm1547_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1212\/WNL.50.3.583","volume":"50","author":"WR Kennedy","year":"1998","unstructured":"Kennedy, W.R., Alter, M. & Sung, J.H. Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 50, 583\u2013593 (1998).","journal-title":"Neurology"},{"key":"BFnm1547_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77\u201379 (1991).","journal-title":"Nature"},{"key":"BFnm1547_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mus.880010406","volume":"1","author":"SP Ringel","year":"1978","unstructured":"Ringel, S.P., Lava, N.S., Treihaft, M.M., Lubs, M.L. & Lubs, H.A. Late-onset X-linked recessive spinal and bulbar muscular atrophy. Muscle Nerve 1, 297\u2013307 (1978).","journal-title":"Muscle Nerve"},{"key":"BFnm1547_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/112.1.209","volume":"112","author":"G Sobue","year":"1989","unstructured":"Sobue, G. et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112, 209\u2013232 (1989).","journal-title":"Brain"},{"key":"BFnm1547_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno, M. et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843\u2013854 (2002).","journal-title":"Neuron"},{"key":"BFnm1547_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ana.410440216","volume":"44","author":"M Li","year":"1998","unstructured":"Li, M. et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann. Neurol. 44, 249\u2013254 (1998).","journal-title":"Ann. Neurol."},{"key":"BFnm1547_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1126\/science.3353726","volume":"240","author":"CS Chang","year":"1988","unstructured":"Chang, C.S., Kokontis, J. & Liao, S.T. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240, 324\u2013326 (1988).","journal-title":"Science"},{"key":"BFnm1547_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1210\/er.2002-0032","volume":"25","author":"CA Heinlein","year":"2004","unstructured":"Heinlein, C.A. & Chang, C. Androgen receptor in prostate cancer. Endocr. Rev. 25, 276\u2013308 (2004).","journal-title":"Endocr. Rev."},{"key":"BFnm1547_CR9","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1073\/pnas.93.11.5517","volume":"93","author":"S Yeh","year":"1996","unstructured":"Yeh, S. & Chang, C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA 93, 5517\u20135521 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1547_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1210\/edrv.23.2.0460","volume":"23","author":"CA Heinlein","year":"2002","unstructured":"Heinlein, C.A. & Chang, C. Androgen receptor (AR) coregulators: an overview. Endocr. Rev. 23, 175\u2013200 (2002).","journal-title":"Endocr. Rev."},{"key":"BFnm1547_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/87842","volume":"7","author":"A McCampbell","year":"2001","unstructured":"McCampbell, A. & Fischbeck, K.H. Polyglutamine and CBP: fatal attraction? Nat. Med. 7, 528\u2013530 (2001).","journal-title":"Nat. Med."},{"key":"BFnm1547_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","volume":"29","author":"MY Sherman","year":"2001","unstructured":"Sherman, M.Y. & Goldberg, A.L. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29, 15\u201332 (2001).","journal-title":"Neuron"},{"key":"BFnm1547_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","volume":"35","author":"CA Ross","year":"2002","unstructured":"Ross, C.A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35, 819\u2013822 (2002).","journal-title":"Neuron"},{"key":"BFnm1547_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/hmg\/7.4.693","volume":"7","author":"DE Merry","year":"1998","unstructured":"Merry, D.E., Kobayashi, Y., Bailey, C.K., Taye, A.A. & Fischbeck, K.H. Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 7, 693\u2013701 (1998).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1547_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/jnr.10746","volume":"74","author":"V Tarlac","year":"2003","unstructured":"Tarlac, V. & Storey, E. Role of proteolysis in polyglutamine disorders. J. Neurosci. Res. 74, 406\u2013416 (2003).","journal-title":"J. Neurosci. Res."},{"key":"BFnm1547_CR16","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/hmg\/ddg161","volume":"12","author":"LM Mandrusiak","year":"2003","unstructured":"Mandrusiak, L.M. et al. Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor. Hum. Mol. Genet. 12, 1497\u20131506 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1547_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0361-9230(01)00583-4","volume":"56","author":"AM Beauchemin","year":"2001","unstructured":"Beauchemin, A.M. et al. Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy. Brain Res. Bull. 56, 285\u2013297 (2001).","journal-title":"Brain Res. Bull."},{"key":"BFnm1547_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0896-6273(04)00110-2","volume":"41","author":"M Katsuno","year":"2004","unstructured":"Katsuno, M. & Sobue, G. Polyglutamine diminishes VEGF; passage to motor neuron death? Neuron 41, 677\u2013679 (2004).","journal-title":"Neuron"},{"key":"BFnm1547_CR19","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nm878","volume":"9","author":"M Katsuno","year":"2003","unstructured":"Katsuno, M. et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 9, 768\u2013773 (2003).","journal-title":"Nat. Med."},{"key":"BFnm1547_CR20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","volume":"13","author":"M Minamiyama","year":"2004","unstructured":"Minamiyama, M. et al. Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 13, 1183\u20131192 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1547_CR21","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","volume":"24","author":"ES Chevalier-Larsen","year":"2004","unstructured":"Chevalier-Larsen, E.S. et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci. 24, 4778\u20134786 (2004).","journal-title":"J. Neurosci."},{"key":"BFnm1547_CR22","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1021\/jm020200g","volume":"45","author":"H Ohtsu","year":"2002","unstructured":"Ohtsu, H. et al. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. J. Med. Chem. 45, 5037\u20135042 (2002).","journal-title":"J. Med. Chem."},{"key":"BFnm1547_CR23","doi-asserted-by":"publisher","first-page":"50855","DOI":"10.1074\/jbc.M209466200","volume":"277","author":"JL Walcott","year":"2002","unstructured":"Walcott, J.L. & Merry, D.E. Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J. Biol. Chem. 277, 50855\u201350859 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm1547_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0896-6273(04)00082-0","volume":"41","author":"BL Sopher","year":"2004","unstructured":"Sopher, B.L. et al. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron 41, 687\u2013699 (2004).","journal-title":"Neuron"},{"key":"BFnm1547_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nm1298","volume":"11","author":"M Waza","year":"2005","unstructured":"Waza, M. et al. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med. 11, 1088\u20131095 (2005).","journal-title":"Nat. Med."},{"key":"BFnm1547_CR26","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/annonc\/mdg316","volume":"14","author":"MP Goetz","year":"2003","unstructured":"Goetz, M.P., Toft, D.O., Ames, M.M. & Erlichman, C. The Hsp90 chaperone complex as a novel target for cancer therapy. Ann. Oncol. 14, 1169\u20131176 (2003).","journal-title":"Ann. Oncol."},{"key":"BFnm1547_CR27","first-page":"986","volume":"8","author":"DB Solit","year":"2002","unstructured":"Solit, D.B. et al. 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2\/neu and inhibits the growth of prostate cancer xenografts. Clin. Cancer Res. 8, 986\u2013993 (2002).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1547_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1210\/mend.12.3.0075","volume":"12","author":"RL Barent","year":"1998","unstructured":"Barent, R.L. et al. Analysis of FKBP51\/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes. Mol. Endocrinol. 12, 342\u2013354 (1998).","journal-title":"Mol. Endocrinol."},{"key":"BFnm1547_CR29","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1128\/MCB.15.12.6804","volume":"15","author":"DF Smith","year":"1995","unstructured":"Smith, D.F. et al. Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol. Cell. Biol. 15, 6804\u20136812 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm1547_CR30","first-page":"4003","volume":"61","author":"I Hostein","year":"2001","unstructured":"Hostein, I., Robertson, D., DiStefano, F., Workman, P. & Clarke, P.A. Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis. Cancer Res. 61, 4003\u20134009 (2001).","journal-title":"Cancer Res."},{"key":"BFnm1547_CR31","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1200\/JCO.2005.00.612","volume":"23","author":"U Banerji","year":"2005","unstructured":"Banerji, U. et al. Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies. J. Clin. Oncol. 23, 4152\u20134161 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFnm1547_CR32","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1158\/0008-5472.CAN-04-4458","volume":"65","author":"JT Price","year":"2005","unstructured":"Price, J.T. et al. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Res. 65, 4929\u20134938 (2005).","journal-title":"Cancer Res."},{"key":"BFnm1547_CR33","doi-asserted-by":"publisher","first-page":"36499","DOI":"10.1074\/jbc.M202824200","volume":"277","author":"TH Thin","year":"2002","unstructured":"Thin, T.H. et al. Mutations in the helix 3 region of the androgen receptor abrogate ARA70 promotion of 17beta-estradiol-induced androgen receptor transactivation. J. Biol. Chem. 277, 36499\u201336508 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm1547_CR34","doi-asserted-by":"publisher","first-page":"32444","DOI":"10.1074\/jbc.M313963200","volume":"279","author":"L Wang","year":"2004","unstructured":"Wang, L. et al. Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells. J. Biol. Chem. 279, 32444\u201332452 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm1547_CR35","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1523\/JNEUROSCI.22-12-04897.2002","volume":"22","author":"GA Garden","year":"2002","unstructured":"Garden, G.A. et al. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice. J. Neurosci. 22, 4897\u20134905 (2002).","journal-title":"J. Neurosci."},{"key":"BFnm1547_CR36","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/hmg\/10.10.1039","volume":"10","author":"H Adachi","year":"2001","unstructured":"Adachi, H. et al. Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum. Mol. Genet. 10, 1039\u20131048 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1547_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s004010050497","volume":"92","author":"S Terao","year":"1996","unstructured":"Terao, S. et al. Age-related changes in human spinal ventral horn cells with special reference to the loss of small neurons in the intermediate zone: a quantitative analysis. Acta Neuropathol. (Berl.) 92, 109\u2013114 (1996).","journal-title":"Acta Neuropathol. (Berl.)"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1547","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:28:31Z","timestamp":1684448911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BFnm1547"],"URL":"https:\/\/doi.org\/10.1038\/nm1547","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}